CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.32
+0.02 (+1.54%)
Open$1.33
Previous Close$1.30
Day High$1.34
Day Low$1.28
52W High$2.33
52W Low$1.23
Volume—
Avg Volume65.8K
Market Cap199.13M
P/E Ratio—
EPS$-0.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,739.4% upside
Current
$1.32
$1.32
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.47M | 20.00M | 18.14M |
| Net Income | 5.10M | 5.20M | 4.96M |
| Profit Margin | 23.8% | 26.0% | 27.3% |
| EBITDA | 10.24M | 10.30M | 9.42M |
| Free Cash Flow | 5.58M | 6.38M | 6.16M |
| Rev Growth | +3.9% | -4.2% | -9.3% |
| Debt/Equity | 1.16 | 1.28 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |